Skip to main content

CMO Supplier Quality Agreements :- How to Comply with new FDA and EU Guidelines for Contract Drug Manufacturer

Compliance Key INC - Compliance Online Training


                                           Roger Cowan
Roger Cowan is the Keynote Spaker at Compliance Key Inc. He is the founder and owner of R Cowan Consulting Services LLC, a consulting company specializing primarily in the area of pharmaceutical contract manufacturing. He has 35 years experience in pharmaceutical quality assurance and manufacturing.
 Webinar Id: LSHCRC007
 10:00 AM PT | 01:00 PM ET
 12/07/2017
 Duration 60 mins
Overview
A Quality Agreement is a contract between a pharmaceutical firm and a GMP Contract Manufacturer detailing the responsibilities of each party in assuring the quality, safety, and efficacy of the manufactured drug. 
Recently, the EU and the FDA issued regulatory guidance to bring some clarity and consistency to these quality contracts:
  • EU GMP Chapter 7 "Outsourced Activities" (Revised)
  • Draft Guidance for Industry -"Contract Manufacturing Arrangements for Drugs: Quality Agreements" May 2013
Why should you attend this webinar?
In 2010, the global CMO market was estimated at $26 billion dollars. Year on year growth has been 10.7% since 2008. The increasing use of outsourcing in the pharmaceutical industry along with recent well-publicized quality issues with CMOs, make it a necessity to have excellent quality oversight of external manufacturers to provide assurance of GMP compliance. A Quality Agreement is one tool used to accomplish this objective. 
This Webinar presentation will provide a thorough understanding of the content that is expected in Quality Agreements from a regulatory perspective. 
Control of suppliers such as Contract Manufacturing Organizations has always been a requirement of the FDA and EU. With the issuance of these new regulatory documents; the expectation is that there will be a written documentation of this control. Proof of this control can be presented to FDA / EU inspectors in the form of a Quality Agreement which is specific to a particular CMO. 
Each proposed section of a Quality Agreement is fully analyzed and suggested content is written with the new guidelines taken into consideration. Comparison of the two regulatory documents is presented with differences highlighted and discussed.
A detailed discussion of Quality Agreement topics such as change control, documentation, facilities, and equipment, lab controls, sub-contracting, etc. is covered. 
The latest status of the FDA draft guidance is discussed and a review of comments from industry is included.
Areas Covered in the Session:
  • The Who and What of a good Quality Agreement
  • What a Quality Agreement is - and is not
  • Responsibilities of the owner vs. contract facility
  • GMP responsibilities
  • A comparison of the new guidelines from the FDA and the EU
Who can Benefit:
  • Quality Assurance
  • External Manufacturing / Outsourcing
  • Quality Auditing
  • Technology Transfer
  • Regulatory Affairs / Compliance 
  • Supply Chain
  • Purchasing
  • Risk Management
 Compliance Key INC
Labels:
Location: United States

Comments

Post a Comment

Popular posts from this blog

New 2019 HIPAA Guidance on De-Identifying Protected Health Information

Compliance Key  -   HIPAA Compliance Training Overview This seminar will be addressing how practice/business managers or compliance officers need to get their HIPAA house in order, as HIPAA is now fully enforced and the government is not using kid gloves anymore. It will also address major 2019 changes taking place with the Health and Human Services regarding the enforcement of the HIPAA law as well as detailed discussions on the Phase 2 audit process and current events regarding HIPAA cases (both in courtrooms and from real-life Audits). Our instructor - Mr. Brian Tuttle  has over 20 years of experience in working as Compliance auditor and has been an expert witness on multiple HIPAA cases. He`ll thoroughly explain on HOW and in WHAT scenarios patients can claim for cash remedies. More importantly, Brian will show you how to limit those risks by simply taking proactive steps and utilizing best practices. Why should you attend this seminar? This Seminar will go over s
Post a Comment
Read more

SOX Compliance: Accounts Receivable Risks and Controls

Overview The accounts receivable process includes the sub-cycles of acquiring and accepting customer orders; writing sales contracts; granting customer credit; shipping or otherwise delivering products or services; billing and recording sales and lease transactions; maintaining and monitoring accounts receivable; instituting effective collection procedures; recording and controlling cash receipts; establishing pricing and promotional activities; and properly valuing receivable balances. In management's selection of procedures and techniques of control, the degree of control implemented is a matter of reasonable business judgment. The common guideline used in determining the degree of internal controls implementation is that the cost of a control should not exceed the benefit derived. The Order to Cash Process (O2C) Process is comprised of several sub-processes that must have a foundation of internal controls for SOX 404 certification process. This webinar wil
Post a Comment
Read more

How to Return Manufacturing to America Using Total Cost of Ownership Analysis?

How to Return Manufacturing to America Using Total Cost of Ownership Analysis? Michele Nash-Hoff Michele is founder and president of ElectroFab Sales, a sales agency specializing in helping manufacturers select the right processes for their products since 1985. She is currently a director on the board of the and the San Diego Inventors Forum and is also Chair of the California chapter of the Coalition for a Prosperous America. Michele is the author of Rebuild Manufacturing - the key to American Prosperity and Can American Manufacturing Be Saved? Why We Should and How We Can available at www.amazon.com. She has written regular articles for IndustryWeek?s e newsline, as well as many other e........ Read More Overview Moving manufacturing offshore led to the loss of 5.8 million manufacturing jobs and the loss of 60,000 companies and since the year 2000. What was the impact on the American economy? Is manufacturing returning to America? In this webinar, expert
Post a Comment
Read more